Biotech holding company Roivant Sciences raised $200M in funding at a whopping $7B valuation [TechCrunch Blog]
Axon Enterprise, Inc. (AXON)
Last axon enterprise, inc. earnings: 2/7 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.axovant.com/investors/sec-filings
Company Research
Source: TechCrunch Blog
Roivant Sciences has had a bumpy couple of years, but that isn’t stopping investors from pouring more money into the four-year-old company, which aims to one day be a giant holding company for dozens of independent biopharmaceutical spinoffs — and is fulfilling that vision by creating one independent company at a time. Roivant’s newest financing event: a $200 million raise at a post-money valuation of $7 billion, led by NovaQuest Capital Management, which is an investor in two of Roivant’s companies; RTW Investments, a young investment firm focused on biopharma; and an unnamed “large U.S. insurance company,” according to a company spokesman. The round follows a $1.1 billion round led last year by SoftBank’s Vision Fund, which Roivant now says was closed at a post-money valuation of $5.6 million, though it didn’t necessarily look like money well spent at the time. To wit, r oughly one week after the financing closed last August, Axovant Sciences, one of Roivan
Show less
Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXON alerts
High impacting Axon Enterprise, Inc. news events
Weekly update
A roundup of the hottest topics
AXON
News
- Axon Enterprise, Inc. (NASDAQ: AXON) had its price target raised by analysts at Barclays PLC from $308.00 to $381.00. They now have an "overweight" rating on the stock.MarketBeat
- Wall Street Analysts Think Axon (AXON) Is a Good Investment: Is It? [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]Yahoo! Finance
- Why Axon Enterprise Stock Dipped Today [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise (AXON) Q1 Earnings & Revenues Top Estimates [Yahoo! Finance]Yahoo! Finance
AXON
Earnings
- 5/6/24 - Beat
AXON
Sec Filings
- 5/9/24 - Form 144
- 5/9/24 - Form 144
- 5/9/24 - Form 144
- AXON's page on the SEC website